Humacyte, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Humacyte, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
Humacyte, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -1.14K %, a 928% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	-1.14K	-1.27K	-928%	Sep 30, 2024
Q2 2024	1.09K	+986	+927%	Jun 30, 2024
Q1 2024	341	+254	+291%	Mar 31, 2024
Q4 2023	225	+129	+136%	Dec 31, 2023
Q3 2023	137	+27.2	+24.7%	Sep 30, 2023
Q2 2023	106	-41.4	-28%	Jun 30, 2023
Q1 2023	87	+818		Mar 31, 2023
Q4 2022	95.4	+173		Dec 31, 2022
Q3 2022	110	+139		Sep 30, 2022
Q2 2022	148	+153		Jun 30, 2022
Q1 2022	-731			Mar 31, 2022
Q4 2021	-77.8			Dec 31, 2021
Q3 2021	-29.2			Sep 30, 2021
Q2 2021	-5.03			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.